Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zotefoams is a UK-listed advanced materials company focused on the development, manufacture, and sale of supercritical foam products and related technologies. The company produces closed-cell crosslinked polyolefin foams and high-performance foams used across footwear, aerospace, transportation, industrial, construction, insulation, packaging, and selected medical applications. Its core brands include AZOTE, ZOTEK, ECOZOTE, and T-FIT, and it also owns MuCell microcellular foaming technology for plastics processing. Although Zotefoams serves healthcare and biotech manufacturing niches through insulation and medical-grade foam products, it is not a biotech, pharma, or healthcare therapeutics company. The business is commercial-stage, globally distributed, and generates revenue primarily from materials sales and technology licensing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zotefoams.